Fig. 1 · Structure
Documents & Downloads
SCL-1
PD-1/PD-L1Inhibitor
SCL-1 is an orally active inhibitor of the PD-1/PD-L1 pathway, effectively blocking the interaction between PD-1 and PD-L1. This compound enhances the proliferation of T cells, B cells, and natural killer cells, contributing to robust antitumor activity. SCL-1 mediates tumor growth inhibition through the induction of effector T cells within the tumor environment and by upregulating long non-coding RNAs that act as neoantigens, facilitating cytotoxic T lymphocyte activation. This reagent is valuable for cancer research, particularly in studies focused on triple-negative breast cancer.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1061105-16-5 |
| Applications | PD-1/PD-L1Inhibitor |
| Formula | C18H23F3N6O |
| Molecular Weight | 396.41 |
| SMILES | CC1CCCCN1C(C2CCN(CC2)C3=NN4C(C=C3)=NN=C4C(F)(F)F)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.